Anti-androgenic activities of Ganoderma lucidum

被引：80
作者：
Fujita, R
Liu, J
Shimizu, K
Konishi, F
Noda, K
Kumamoto, S
Ueda, C
Tajiri, H
Kaneko, S
Suimi, Y
Kondo, R [1 ]
机构：
[1] Kyushu Univ, Fac Agr, Dept Forest & Forest Prod Sci, Fukuoka 8128581, Japan
[2] Chlorella Ind Co Ltd, Res Labs, Fukuoka 8330056, Japan
[3] Yamaya Conmunicat Co Ltd, Fukuoka 8130061, Japan
[4] Fukuoka Prefecture Forest Res & Extens Ctr, Fukuoka 8390827, Japan
[5] Bisoken & Co Ltd, Oita 8710011, Japan
来源：
JOURNAL OF ETHNOPHARMACOLOGY | 2005年 / 102卷 / 01期
关键词：
5; alpha-reductase; Ganoderma lucidum; Ganodermataceae; anti-androgen activities; benign prostatic hyperplasia (BPH);
D O I：
10.1016/j.jep.2005.05.041
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
The inhibitory effects of methanol extracts of 19 edible and medicinal mushrooms on 5 alpha-reductase activity were examined. The extract of Ganoderma lucidum Fr. Krast (Ganodermataceae) showed the strongest 5 alpha-reductase inhibitory activity. The treatment of the fruit body of Ganoderma lucidum or the extract prepared from it significantly inhibited the testosterone-induced growth of the ventral prostate in castrated rats. These results showed that Ganoderma lucidum might be a useful ingredient for the treatment of benign prostatic hyperplasia (BPH). (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：107 / 112
页数：6
相关论文
共 27 条
  • [1] STRUCTURAL AND BIOCHEMICAL-PROPERTIES OF CLONED AND EXPRESSED HUMAN AND RAT STEROID 5-ALPHA-REDUCTASES
    ANDERSSON, S
    RUSSELL, DW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) : 3640 - 3644
  • [2] Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
    Bartsch, G
    Rittmaster, RS
    Klocker, H
    [J]. EUROPEAN UROLOGY, 2000, 37 (04) : 367 - 380
  • [3] Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia
    Bartsch, G
    Rittmaster, RS
    Klocker, H
    [J]. WORLD JOURNAL OF UROLOGY, 2002, 19 (06) : 413 - 425
  • [4] Bonkhoff H, 1996, PROSTATE, V29, P261, DOI 10.1002/(SICI)1097-0045(199610)29:4<261::AID-PROS7>3.0.CO
  • [5] 2-E
  • [6] Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: Two case reports
    de la Taille, A
    Hayek, OR
    Burchardt, M
    Burchardt, T
    Katz, AE
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2000, 6 (05) : 449 - 451
  • [7] Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer
    DiPaola, RS
    Zhang, HY
    Lambert, GH
    Meeker, R
    Licitra, E
    Rafi, MM
    Zhu, BT
    Spaulding, H
    Goodin, S
    Toledano, MB
    Hait, WN
    Gallo, MA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (12) : 785 - 791
  • [8] Trends in alternative medicine use in the United States, 1990-1997 - Results of a follow-up national survey
    Eisenberg, DM
    Davis, RB
    Ettner, SL
    Appel, S
    Wilkey, S
    van Rompay, M
    Kessler, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18): : 1569 - 1575
  • [9] Fukuta Y, 1999, J PHARMACOL EXP THER, V290, P1013
  • [10] The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
    Giovannucci, E
    Stampfer, MJ
    Krithivas, K
    Brown, M
    Brufsky, A
    Talcott, J
    Hennekens, CH
    Kantoff, PW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) : 3320 - 3323
123